Sydney Brehany, MD
Medical Oncology · Des Moines, IANPI 1821529363
Payments from drug & device makers
What this record shows
4 manufacturers reported payments, led by AstraZeneca at 48.5% of the total. That places this record below the midpoint for medical oncology clinicians in IA, where the typical reported total is $879.
Across 4 payments — averaging $35.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$68
- Tersera Therapeutics LLC$34
- Myriad Genetic Laboratories, Inc.$21
- E.r. Squibb & Sons, L.L.C.$17
What the payments were for
- Food & beverage$7351%
- Education$6849%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $68 |
| Tersera Therapeutics LLC | 1 | $34 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
How this compares
$141 in reported general payments places this provider in the 30th percentile of 47 medical oncology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 22 | $354,291 |
| Anastrozole | 86 | $1,601 |
| Letrozole | 43 | $1,340 |
| Gabapentin | 20 | $333 |
| Tamoxifen Citrate | 15 | $300 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Des Moines
- Mathew WehbeDes Moines$120K
- Giselle MeryDes Moines$12K
- Emily BrugioniDes Moines$6K
- Millicent AmankwahDes Moines$3K
- Steven HeddingerDes Moines$3K
- Christian SchultheisDes Moines$432
- Matthew HillDes Moines$378
- Magdy ElsawyDes Moines$353
- Robert BehrensDes Moines$345
- Bradley HiattDes Moines$148
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.